Literature DB >> 7432727

Prenatal diagnosis and management of nonimmunologic hydrops fetalis.

J E Maidman, C Yeager, V Anderson, G Makabali, J P O'Grady, J Arce, D M Tishler.   

Abstract

As problem pregnancies are increasingly subjected to ultrasound evaluation, the prenatal diagnosis of hydrops fetalis is being made more and more frequently. The authors encountered 5 cases of this disorder in 12,830 deliveries (1:2566) and made the diagnosis prior to delivery in 4 of the 5 cases. Amniocentesis and amniotic fluid bilirubin determination have been performed in association with ultrasound scan and a battery of other diagnostic tests, and the results have been correlated with fetal outcome. In general the combination of fetal ascites and increased amniotic fluid bilirubin denotes a poor fetal prognosis. Unless there are other mitigating circumstances, a conservative course of management is recommended.

Entities:  

Mesh:

Year:  1980        PMID: 7432727

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Fetal Ebstein anomaly--a rare cause of non-immune hydrops.

Authors:  A Suneja; N Agarwal; S Gupta; G Dev; N Jain
Journal:  Indian J Pediatr       Date:  1996 Nov-Dec       Impact factor: 1.967

2.  [Controlled ultrasound therapy of the fetus].

Authors:  M Hansmann
Journal:  Arch Gynecol       Date:  1985

3.  Non-immunologic hydrops fetalis: a review of 27 cases.

Authors:  P J Iliff; J M Nicholls; J W Keeling; J D Gough
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

4.  Diagnosis and management of non-immune hydrops in the newborn.

Authors:  T Stephenson; J Zuccollo; M Mohajer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

5.  Severe hydrops fetalis due to congenital supraventricular tachycardia.

Authors:  A J Rein; C Lotan; K J Goiten; A Simcha
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.